Pedro José García-Ruiz

Pedro José García-Ruiz

Auto-generated profile, based on publicly available information

Pedro José García-Ruiz

Hospital Fundación Jiménez Díaz, 28040 Madrid, Spain

Research Focus & Metrics

Academic Career Length

39Years (1988-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 February 2000 in Gait & Posture
Verified
Journal Article
Closed access
HGH.KErr Graham
H.KErr Graham
KAK.ROger Aoki
K.ROger Aoki
IAIlona Autti-Rämö
Ilona Autti-Rämö
RBRoslyn N Boyd
Roslyn N Boyd
MDMauricio R Delgado
Mauricio R Delgado
JWJörg Wissel
Jörg Wissel

16 January 2014 in Journal of Neurology, Neurosurgery & Psychiatry
Verified
Journal Article
Closed access
PGP. J. Garcia-Ruiz
P. J. Garcia-Ruiz
JMJuan Carlos Martinez-Castrillo
Juan Carlos Martinez-Castrillo
AAA. Alonso-Canovas
A. Alonso-Canovas
ABA. Herranz Barcenas
A. Herranz Barcenas
LDLYDIA VELA DESOJO
LYDIA VELA DESOJO
IMIgnacio Mahíllo-Fernández
Ignacio Mahíllo-Fernández
Impulse control disorders (ICDs) encompass a wide spectrum of abnormal behaviour frequently found in cases of Parkinson's disease (PD) treated with dopamine agonists (DAs). The main aim of this study was to analyse ICD prevalence with different DAs. We carried out a multicentre transversal study to evaluate the presence of ICDs in patients with PD chronically treated (>6 months) with a single non-ergolinic DA (pramipexole, ropinirole, or rotigotine). Clinical assessment of ICD was performed using the Questionnaire for Impulsive-Compulsive Disorders in Parkinson's disease. Thirty-nine per cent of patients (91/233) fulfilled the clinical criteria for ICD. The group of patients with ICD symptoms (ICD+) differed from those without ICD symptoms (ICD-) in younger age and type of DA intake. Oral DA treatment (pramipexole and ropinirole) was associated with higher risk of ICDs compared with transdermal DA (rotigotine): 84/197 (42%) patients treated with oral DA developed ICD, versus 7/36 (19%) patients treated with transdermal DA (Fisher's exact text <0.01). In univariate analysis, a younger age (p<0.01), treatment with rasagiline (p<0.05), and especially treatment with an oral DA (pramipexole or ropinirole) (p<0.01) were significantly associated with ICD. Multivariate analysis confirmed that oral DA remained significantly associated with ICD (p: 0.014, OR: 3.14; 1.26-7.83). ICD was significantly associated with the use of the non-ergolinic oral DA (pramipexole and ropinirole) when compared with transdermal non-ergolinic DA (rotigotine). Since pramipexole, ropinirole and rotigotine are non-ergolinic DAs with very similar pharmacodynamic profiles, it is likely that other factors including route of administration (transdermal vs oral) explain the difference in risk of ICD development.

28 April 2008 in Movement Disorders
Verified
Journal Article
Closed access
PDF file
PRPedro J. García Ruiz
Pedro J. García Ruiz
ÁIÁngel Sesar Ignacio
Ángel Sesar Ignacio
BPBegoña Ares Pensado
Begoña Ares Pensado
AGAlfonso Castro García
Alfonso Castro García
FFFernando Alonso Frech
Fernando Alonso Frech
ICIvana Zamarbide Capdepon
Ivana Zamarbide Capdepon

1 September 2015 in Parkinsonism & Related Disorders
Verified
Journal Article
Closed access
CTClaudia Trenkwalder
Claudia Trenkwalder
Kallol (K) Chaudhuri also Ray-ChaudhuriKallol (K) Chaudhuri also Ray-Chaudhuri
Kallol (K) Chaudhuri also Ray-Chaudhuri
PRPedro J. García Ruiz
Pedro J. García Ruiz
PLPeter LeWitt
Peter LeWitt
RKRegina Katzenschlager
Regina Katzenschlager
KWKaroline Wenzel
Karoline Wenzel

1 September 2016 in Journal of the Neurological Sciences
Verified
Journal Article
Closed access
LDLYDIA VELA DESOJO
LYDIA VELA DESOJO
JMJuan Carlos Martinez-Castrillo
Juan Carlos Martinez-Castrillo
PRP. García Ruiz
P. García Ruiz
Carmen Gasca-SalasCarmen Gasca-Salas
Carmen Gasca-Salas
YMY. Macías Macías
Y. Macías Macías
RMR. Marasescu
R. Marasescu

1 March 1997 in Drug Safety
Verified
Journal Article
Closed access
PDF file
FJFélix Javier Jiménez-Jiménez
Félix Javier Jiménez-Jiménez
PGPedro José García-Ruiz
Pedro José García-Ruiz
JMJosé Antonio Molina
José Antonio Molina